A detailed break-out of the company’s financial results shows its sports medicine product sales slumped this quarter, sitting at $56.7 million compared to $60.4 million in the same period in 2010. Other product sales, which consist principally of Coblation spine product sales, declined $0.5 million in Q1 of 2011 compared to the same period of 2010.
ArthroCare’s ENT product line, however, experienced a $2.6 million increase in sales.
Read the company news release about ArthroCare’s financial results.
Related Articles on Device Company Financial Results:
Greatbatch Orthopedic Line Sales Increase 34% to $39.6M
Zimmer Posts $1.12B in Q1 Net Sales, 5% Increase
MiMedx Q1 Revenues Up Following Surgical Biologics Acquisition
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
